VTA Symposium Profile picture
May 5 13 tweets 5 min read Twitter logo Read on Twitter
Next up in Prof Guy Richards @ProfGuyRichards who will be talking about Ventilatory Lessons Learnt from COVID. #VTA23
In SA, large numbers of patients who would normally be admitted to ICU for ventilation were instead given support through CPAP and HFNC in wards (and sometimes parking lots...) because of resource limitations. #VTA23
An SA study (n=293) with patients with a mean PF ratio of 68 who were given HFNC, had 47% of patients who survived to weaning. If HFNC failed, you had a risk of mortality of 92%! Predictors of success included a ROX-6 score of >4.4. #VTA23
CPAP, which suffers from patient intolerance, had some early failures - a study showed using normal nasal prongs vs CPAP resulted in no difference in mortality. #VTA23
However, helmet NIV may reduce mortality (RR 0.56) and intubation (0.45) in both hypoxaemic and hypercapneic patients. #VTA23
In conclusion, these devices (CPAP, NIV and HFNC) were used to reduced ICU demand. #VTA23
doi.org/10.1001/jama.2…
What about the ventilatory strategies used in these patients:
Low Volume tidal ventilation (±6ml/kg of IBW), with a Pplat =< 30cmH20 and Driving Pressure =< 15cmH20. #VTA23
There was also the advent of awake proning. Early data from COVID showed that this slightly reduced the progression to the need for intubation. A later more pragmatic trial showed no benefit. This may be because patients were reluctant to stay prone for the required period.#VTA23
Proning during MV was not associated with improvement in survival itself, however if there was a response in the PF ratio to proning, it indicated the patient was more likely to survive! #VTA23
Regarding timing of intubation, recent data showed that very early intubation and late intubation were shown to be associated with increased mortality.
#VTA23
doi.org/10.1186/s12871…
The advent of a permissive hypoxaemic strategy also came to the fore during COVID. Targets had to be altered beyond what we were often comfortable with. #VTA23
For those interested, the ROX-6 index was the ROX score (SpO2 x RR / FiO2) at 6hours post initiation of the oxygenation modality. #VTA23
All the above was cited, although I was unable to catch all the citations! #VTA23 I'm sure @ProfGuyRichards will be happy to share any references if asked! Thanks for a great talk Prof, and sorry for what I missed!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with VTA Symposium

VTA Symposium Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VTA_Symposium

May 6
Anthony Holley speaking on 'Tracheostomy - When and How?'
#VTA23 #critcare #FOAMcc
Why do we put tracheostomies in patients though?
The rationale for a trachy in ICU is that there are respiratory mechanical benefit (compare to a tracheal tube and a native airway). There are many patient care benefits - oral care, feeding, etc...
#VTA23
There are problems, including the potential for real patient harm. Tracheostomy emergencies are a problem. Complications (Immediate, Early and Late) are encountered in 30% of patients. #VTA23
Read 9 tweets
May 6
Next is Donna Hamel, speaking on 'PEEP Titration and Recruitment'
#VTA23 #critcare #FOAMcc
PEEP is important - it improves oxygenation, and is an essential component of lung protective strategies.
But PEEP also has some problems - it can cause hypotension and increased pulmonary vascular resistance.
So how does one get optimal PEEP?
#VTA23
Optimal PEEP has no clear universal definition.
Maybe we should look for appropriate PEEP - a PEEP value that results in adequate oxygenation with the lowest risk of overdistension.
#VTA23
Read 5 tweets
May 6
Prof Anthony Holley is speaking next on 'Respiratory Support in the Trauma Patient' #VTA23 #critcare #FOAMcc
The 'trauma' patient is not a single disease entity, but ultimately a mechanism that is characterised by a shared multitude of pathophysiological patterns (TBI, lung contusion, etc...) and interventions (surgery, transfusion) that lead to some common disease processes. #VTA23
These common disease processes include TRALI, ARDS, TIC and many more.
Of concern, ARDS is not uncommon in trauma patients.
#VTA23
Read 6 tweets
May 6
Next up are two of the Occupational Therapists from CHBAH - Marche van der Heyden and Tiffany Fairbairn - speaking on 'Sensory Stimulation in Critical Care'.
#VTA23 #critcare #FOAMcc
Sensory stimulation is emerging in critical care as a modality to re-establish normal functioning. Our senses are our connection to the world. There are 8 (not 5!) senses - auditory, olfactory, gustatory, visual, tactile/touch, vestibular, proprioception and interoception. #VTA23
The lesser known of these - vestibular, proprioception and interoception - all are key in self-soothing...
Interoception is the sense how different parts of our 'deep' body are feeling. There are a few activities that include all 8 senses - for example eating.
#VTA23
Read 9 tweets
May 6
Midmorning #VTA23 session starting - lots of short talks so expect quick changes in topic! #critcare #FOAMcc
Michael Gentile - Is PARDIE Changing Our View of Paediatric ARDS?
#VTA23 #FOAMcc #critcare
PARDIE stands for Pediatric ARDS Incidence and Epidemiology study. This study is one of the results of the PALISI Conference Group.
doi.org/10.1016/S2213-…
#VTA23
Read 7 tweets
May 6
Last up for the morning session is John Davies, who is talking about 'Mechanical Ventilation during ECMO: all, some or none'.
#VTA23 #FOAMcc #critcare
Essential to remember the components of lung protective ventilation - tidal volume, plateau pressure, respiratory rate, PEEP, FiO2.
#VTA23
Do the rules of LPV change when the patient is on ECMO.
There is little doubt that (in appropriately selected patients) ECMO has a mortality benefit. Have a look at the CESAR and EOLIA trials:
doi.org/10.1016/S0140-…
doi.org/10.1056/NEJMoa…
#VTA23
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(